LIF NANO RX LTD

Company Registration Number:
08551193 (England and Wales)

Unaudited abridged accounts for the year ended 31 May 2023

Period of accounts

Start date: 01 June 2022

End date: 31 May 2023

LIF NANO RX LTD

Contents of the Financial Statements

for the Period Ended 31 May 2023

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

LIF NANO RX LTD

Company Information

for the Period Ended 31 May 2023




Director: Dr Su Metcalfe
Florian Kemmerich
David Leppert
Andrew Carver
Registered office: Apartment 16 Springs Court
Field Close
Cottingham
England
HU16 5GX
Company Registration Number: 08551193 (England and Wales)

LIF NANO RX LTD

Balance sheet

As at 31 May 2023


Notes

2023
£

2022
£
Fixed assets
Intangible assets: 4 8,590 10,465
Total fixed assets: 8,590 10,465
Current assets
Debtors: 1,112 8,428
Cash at bank and in hand: 6,715 17,537
Total current assets: 7,827 25,965
Creditors: amounts falling due within one year: ( 653 ) ( 70,510 )
Net current assets (liabilities): 7,174 ( 44,545 )
Total assets less current liabilities: 15,764 ( 34,080 )
Creditors: amounts falling due after more than one year: ( 226,410 ) ( 292,410 )
Total net assets (liabilities): ( 210,646 ) ( 326,490 )

The notes form part of these financial statements

LIF NANO RX LTD

Balance sheet continued

As at 31 May 2023


Notes

2023
£

2022
£
Capital and reserves
Called up share capital: 79,001 13,001
Profit and loss account: ( 289,647 ) ( 339,491 )
Shareholders funds: ( 210,646 ) ( 326,490 )

For the year ending 31 May 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 3 October 2023
And Signed On Behalf Of The Board By:

Name: Dr Su Metcalfe
Status: Director

The notes form part of these financial statements

LIF NANO RX LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Intangible fixed assets amortisation policy

    Intangible assets acquired separately from a business are capitalised at cost and are written off in equal instalments over the assets’ expected useful lives, which are the shorter of 10 years or the remaining term of the licence.

LIF NANO RX LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 2. Employees


    2023

    2022
    Average number of employees during the period 1 2

LIF NANO RX LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 3. Off balance sheet disclosure

    No

LIF NANO RX LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 4. Intangible assets

    Total
    Cost £
    At 01 June 2022 18,743
    Additions -
    Disposals -
    Revaluations -
    Transfers -
    At 31 May 2023 18,743
    Amortisation
    Amortisation at 01 June 2022 8,278
    Charge for year 1,875
    On disposals -
    Other adjustments -
    Amortisation at 31 May 2023 10,153
    Net book value
    Net book value at 31 May 2023 8,590
    Net book value at 31 May 2022 10,465

LIF NANO RX LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

5.1.Related party disclosures

Name of related party: Dr Su Metcalfe
Description of relationship:
Director and shareholder
Description of the transaction:
Loan for working capital
Balance at 01 June 2022 292,410
Balance at 31 May 2023 226,410

LIF NANO RX LTD

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 6. Post balance sheet events

    Subsequent to the year end the company ceased trading and has applied to be removed from the Companies House register.